For ACOs · health systems · MA plans
Help your members live their healthiest lives with fewer pills
UnPill runs supervised evidence-based tapers of benzodiazepines, anticholinergics, and CNS-active polypharmacy across your 65+ population.
The medications driving your falls, ED visits, and admissions — safely removed.
Our pharmacists do the work. Each member’s own physician approves every taper. Improved polypharmacy measures for your Stars team. A lighter total-cost-of-care line for your ACO. You get member-level, measure-ready reporting.
What you get
ACOs & risk-bearing groups
Less avoidable utilization in attributed lives
Sedatives and anticholinergics drive the falls, fractures, and delirium behind ED visits and admissions you pay for under risk. We work your population from a claims extract — zero staffing ask on your practices.
Health system pharmacy
A deprescribing service line without new FTEs
Protocols, taper engine, and documentation workflow, run by our pharmacists under your P&T governance and your EHR standards. Your medication safety mandate, executed at scale.
Medicare Advantage plans
Polypharmacy measures moved, member by member
Member-level reporting against the Part D anticholinergic and CNS-polypharmacy measures, plus Part D spend on discontinued drugs. Tapers run through the member's own prescriber, strengthening your network instead of routing around it.
How the program runs
01Identify
We stratify your population from claims or EHR feeds by drug, dose, duration, and comorbidity. Each member’s physician approves or declines every candidate.
02Engage
Nothing starts without the member. We explain why the medication is on the list, what a taper involves, and what to expect — then the member and their physician decide together what to taper. Agreement first, always.
03Taper
Our pharmacists run gradual, protocolized reductions with scheduled check-ins that keep members engaged through every step-down. Any concerning symptom pauses the taper and reaches the treating physician the same day.
04Report
Quarterly member-level reporting: tapers started, completed, paused, reversed; medications discontinued; movement on the polypharmacy measures you track. Full documentation in the EHR of record.
What it looks like per 10,000 members 65+
Model defaults per 10,000 members 65+ — scale linearly to your population. Every assumption is verified against your actual data before we quote impact.
~750 members off a high-risk medication in year one
Each one is a change on your polypharmacy measures and one less fall waiting to happen.
Plugs into your organization, not around it
Members keep their physicians. Physicians keep clinical authority. Your quality and compliance teams see everything.
Zero added burden on practices
Our pharmacists handle outreach, schedules, check-ins, and documentation. Physicians approve candidates and take escalations — nothing else.
Escalation with a contractual SLA
Withdrawal symptoms, falls, mood changes, and risky co-prescriptions pause the taper and reach the treating physician same-day. The response time is in the contract.
Audit-ready documentation
Every touch documented in the EHR of record with time, clinician, and clinical content. For FFS-billing groups, the same documentation supports existing care-management codes per CMS's May 2026 clarification.
See it on your population
Send a de-identified claims extract; we return your exposure by drug class, your addressable cohort, and a measurement plan. No cost, no obligation. We sign a BAA before any identified data moves.